Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Clear cell renal cell carcinoma and Cancer research, with related work in Renal cell carcinoma, DNA methylation, Ex vivo. Notable publications include 'STAT3 regulated ARF expression suppresses prostate cancer metastasis', 'Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin', and 'Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes'.
Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population
Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
MR Thermometry Data Correlate with Pathological Response for Soft Tissue Sarcoma of the Lower Extremity in a Single Center Analysis of Prospectively Registered Patients
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
STAT3 regulated ARF expression suppresses prostate cancer metastasis
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material
Residual γH2AX foci after ex vivo irradiation of patient samples with known tumour-type specific differences in radio-responsiveness
MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin – A multicenter study
The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
Direct Comparison of Targeted MRI-Guided Biopsy with Systematic Transrectal Ultrasound-Guided Biopsy in Patients with Previous Negative Prostate Biopsies